STING & TLR Targeting Therapies
Chief Academic Officer - BILH and BIDMC
Senior VP Oncology & Translational Medicine, Chief Development Officer ad interim - CureVac
Chief of Research & Development - Silicon Therapeutics
Associate Director - AstraZeneca
Senior Director - Discovery Research - Myeloid Therapeutics
Senior Vice President - Discovery, Preclinical Models & Services - GenOway
Associate Director, Translational Applications - Nilogen Oncosystems
Chief Scientific Officer - 4D Pharma PLC
Chief Computational Scientist - Silicon Therapeutics
Chief Scientific Officer, Co-founder & Head of Research & Development - Verseau Therapeutics
Director - Cancer Research & Scientific - Boehringer Ingelheim
Associate Professor - Harvard Medical School
Chief Medical Officer - Seven and Eight Biopharmaceuticals Inc.
Principal Investigator - Institut Curie
Senior Scientist - Cancer Immunotherapy Drug Discovery - Mersana Therapeutics
President and CEO - Decoy Biosystems
Chief Scientific Officer - STipe Therapeutics
M.D. - Innsbruck Medical University
Vice President - Research & Cofounder - Actym Therapeutics
Director - Pharmacology - Codiak Biosciences
Chief Scientific Officer & Executive Vice President - Ryvu Therapeutics
Project Leader - F-star Biotechnology Ltd.
Senior Director & Head of Project Leader Group, Innate Immunity Research Unit - GlaxoSmithKline
Senior Director - Drug Discovery - Vir Biotechnology Inc.
Head of Translational Research & Innovation - Affimed GmbH
Director - Mersana Therapeutics
CSO, Co-founder, Director & Senior VP - Research & Development - Primmune Therapeutics, Inc.
President & CEO - Tallac Therapeutics
Chief Executive Officer - Avidea Technologies
Assistant Professor - Phase, Therapeutics & Melanoma - University of Pittsburgh
Chief Scientific Officer - Synlogic
Associate Professor - Melanoma Medical Oncology - MD Anderson Cancer Center
Chief Medical Officer - Checkmate Pharmaceuticals
Founder, Chief Scientific Officer & Chief Executive Officer - Checkmate Pharmaceuticals
Senior Director - H3 Biomedicine
Co-founder & Vice President - Immunology & Operations - Apros Therapeutics Inc.
CSO - Tollys
Chief Scientific Officer - Trillium Therapeutics Inc
Chief Medical Officer - Bolt Biotherapeutics
Senior Principal Scientist - Merck & Co
Professor - UMass Medical School
Vice President, Biology - Mersana Therapeutics
Co-Founder & Chief Scientific Officer - oNKo-innate
Vice President of Clinical Development - Istari Oncology Inc.
Medical Director - Highlight Therapeutics SL
4D pharma plc
Developing Science, Delivering Therapies
Make better decisions for your translational immune-oncology program with the most clinically-relevant 3D cancer model – 3D-EXplore
Where DNA breaks, our insight begins
Connect with your peers while onsite!